Table 6.

Second primary malignancies from randomization

Type of malignancyAll patients
N = 332
Hematological cancers 
Solid tumors 25 
Nonmelanoma skin cancer 
Gastrointestinal 
Prostate 
CNS 
Lung 
Others 
Total  27 (8.1%) 
Type of malignancyAll patients
N = 332
Hematological cancers 
Solid tumors 25 
Nonmelanoma skin cancer 
Gastrointestinal 
Prostate 
CNS 
Lung 
Others 
Total  27 (8.1%) 

CNS, central nervous system.

RD: 14 patients; IRD: 13 patients.

Close Modal

or Create an Account

Close Modal
Close Modal